CD4 and myeloid sarcoma: Ratios of CD4+CXCR3+/CD4+CCR4+ and CD4+CXCR3+/CD4+CCR3+ were higher in MS patients than HC, which also indicates Th1 dominance in balancing Th1/Th2 responses.